Alzheimer's Drug Discovery Foundation's
BIOMARKER-BASED TARGET ENGAGEMENT STUDIES to SUPPORT CLINICAL DEVELOPMENT of NOVEL THERAPEUTICS for ALZHEIMER'S DISEASE RFP: The Alzheimer's Drug Discovery Foundation (ADDF) and the Alzheimer's Disease Cooperative Study (ADCS) are collaborating to support pilot biomarker-based clinical trials of novel therapeutics for Alzheimer's disease.
Deadline for Receipt of LOI: September 5, 2014
Deadline for Receipt of LOI IISPV: 08/29/2014 (europa@iispv.cat)
Work
C/ Dr. Mallafrè Guasch, 4
Edifici modular Hospital Universitari de Tarragona Joan XXIII
43007 Tarragona
Tel./Fax Work977 24 97 72 http://www.iispv.cathttp://www.iispv.cat
Work
C/ Sant Llorenç, 21
Planta baixa de l'edifici 4 de la Facultat de Medicina i Ciències de la Salut
43201 Reus (Tarragona)
Tel./Fax Work977 75 93 96 / 977 75 93 95
Fax977 75 93 93
http://www.iispv.cathttp://www.iispv.cat